Litcius/Paper detail

Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Wenlin Xu, Meina Lv, Shuyi Wu, Shaojun Jiang, Zhiwei Zeng, Zongwei Fang, Jiafen Qian, Mingrong Chen, Jiana Chen, Jinhua Zhang

2021Cardiovascular Drugs and Therapy22 citationsDOI

Topics & Concepts

MedicineDabigatranEdoxabanApixabanRivaroxabanStroke (engine)WarfarinInternal medicineAtrial fibrillationEngineeringMechanical engineeringAtrial Fibrillation Management and OutcomesIntracerebral and Subarachnoid Hemorrhage ResearchVitamin K Research Studies
Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis | Litcius